Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is 0.04x as of the fiscal period ended Sunday, December 31, 2023.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
0.04x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.23x
median of 360 covered companies
CURRENT VS SECTOR MEDIAN
+101.05%
vs the sector median at left
Kiniksa Pharmaceuticals International, plc
Market Cap
$5.73B
Interest Coverage Ratio
0.04x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.91B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.57B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.04B
Interest Coverage Ratio
10.01x
TTM Avg
10.01x
3Y Avg
9.97x
5Y Avg
7.31x
Market Cap
$5.29B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.16B
Interest Coverage Ratio
-108.87x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.13B
Interest Coverage Ratio
6.97x
TTM Avg
5.98x
3Y Avg
8.44x
5Y Avg
9.07x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kiniksa Pharmaceuticals International, plc (KNSA) | $5.73B | 0.04x | N/A | N/A | N/A |
| CG Oncology Inc. (CGON)vs › | $5.81B | N/A | N/A | N/A | N/A |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.91B | N/A | N/A | N/A | N/A |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.57B | N/A | N/A | N/A | N/A |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $6.04B | 10.01x | 10.01x | 9.97x | 7.31x |
| Doximity, Inc. (DOCS)vs › | $5.36B | N/A | N/A | N/A | N/A |
| CRISPR Therapeutics AG (CRSP)vs › | $5.29B | N/A | N/A | N/A | N/A |
| Cogent Biosciences, Inc. (COGT)vs › | $5.16B | -108.87x | N/A | N/A | N/A |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.13B | 6.97x | 5.98x | 8.44x | 9.07x |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.11B | -55.80x | N/A | N/A | N/A |
Interest Coverage
0.0x
Debt/Equity
0.01
Current Ratio
3.90
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-12-31 | 0.04x |
